WST

West Pharmaceutical Services
D

WST

Arincen83/100B

West Pharmaceutical Services EPS (earnings per share) 1985–2026

West Pharmaceutical Services's diluted EPS in Q3 FY2026, the three months to 30 September 2026, was 3.02 USD, up 56.5% on the same quarter a year before. West Pharmaceutical Services's diluted earnings per share over the last twelve months were 8.91 USD, up 31.8% on the twelve months before. In fiscal year 2025 they were 6.80 USD, up 1.6% on the year before.

Last updated 9 Nov 2026 · Next report 11 Feb 2027

EPS

Growth

Fiscal yearPeriod endingEPSGrowthEPS (basic)
TTM30 Sept 20268.91+31.80%8.97
FY202531 Dec 20256.80+1.64%6.83
FY202431 Dec 20246.69-15.10%6.75
FY202331 Dec 20237.88+1.94%7.99
FY202231 Dec 20227.73-10.84%7.88
FY202131 Dec 20218.67+89.72%8.90
FY202031 Dec 20204.57+42.37%4.68
FY201931 Dec 20193.21+17.15%3.27
FY201831 Dec 20182.74+37.69%2.80
FY201731 Dec 20171.99+4.19%2.04
FY201631 Dec 20161.91+46.92%1.96
FY201531 Dec 20151.30-25.71%1.33
FY201431 Dec 20141.75+11.46%1.79
FY201331 Dec 20131.57+36.52%1.61
FY201231 Dec 20121.15+6.48%1.19
FY201131 Dec 20111.08+13.68%1.12
FY201031 Dec 20100.95-10.38%0.98
FY200931 Dec 20091.06-15.20%1.11
FY200831 Dec 20081.25+22.55%1.33
FY200731 Dec 20071.02+2.00%1.08
FY200631 Dec 20061.00+40.85%1.05
FY200531 Dec 20050.71+26.79%0.75
FY200431 Dec 20040.56-25.33%0.57
FY200331 Dec 20030.75+127.27%0.75
FY200231 Dec 20020.33—0.33
FY200131 Dec 2001-0.09-462.40%-0.09
FY200031 Dec 20000.03-96.09%0.03
FY199931 Dec 19990.64+540.00%0.65
FY199831 Dec 19980.10-85.07%0.10
FY199731 Dec 19970.67+168.00%0.67
FY199631 Dec 19960.25-41.86%0.25
FY199531 Dec 19950.430.00%0.43
FY199431 Dec 19940.43+16.22%0.43
FY199331 Dec 19930.37+19.35%0.37
FY199231 Dec 19920.31—0.32
FY199131 Dec 1991-0.14-307.41%-0.14
FY199031 Dec 19900.07-78.91%0.07
FY198931 Dec 19890.32+18.52%0.32
FY198831 Dec 19880.27+28.57%0.27
FY198731 Dec 19870.21-22.22%0.21
FY198631 Dec 19860.27+12.50%0.27
FY198531 Dec 19850.24—0.24

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about West Pharmaceutical Services's EPS

Source: Financial Modeling Prep